Moscow: The developers of Russia's Sputnik V vaccine are ready to share its technology with France's Sanofi and the UK's GSK companies to comabt covid-19. This information has been shared by the Russian vaccine's official Twitter account on Friday.
The Tweet reads, "#SputnikV is willing to share its technology with Sanofi @sanofi and GSK @GSK to help in developing their next vaccine. A partnership of different producers is the way of the future. Together we are stronger." The sharing of technology will help them with their vaccine development. The statement follows Sanofi's announcement earlier on Friday that the development of their coronavirus vaccine was delayed due to insufficient immune response among senior participants in clinical trials, with the vaccine expected to be ready in late 2021.
The Sputnik V developers also offered foreign vaccine producers their help in In late November. The Russian Gamaleya research institute suggested that UK pharmaceutical company AstraZeneca try to boost the efficacy of its COVID-19 vaccine, combining it with a shot of Russian COVID-19 vaccine Sputnik V.
Also Read:
New Zealand, Cook Islands announce quarantine-free travel bubble
South Korean filmmaker Kim Ki-duk dies of coronavirus
Pfizer COVID vaccine will be given in less than 24-hrs,, says Trump